机构:[1]Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, People’s Republic of China首都医科大学附属北京同仁医院临床科室耳鼻咽喉-头颈外科[2]Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing 100005, China首都医科大学附属北京同仁医院研究所耳鼻咽喉科研究所[3]State Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Beijing 100005, People’s Republic of China[4]Department of Ultrapathology of Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, People’s Republic of China首都医科大学附属天坛医院[5]Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, People’s Republic of China
Protein crystallization is a prevalent phenomenon existing in the formation of intricate protein-assembled structures in living cells. Whether the crystallization of a protein would exert a specific biological function, however, remains poorly understood. Here, we reconstructed a recombinant galectin-10 (gal-10) protein and artificially engineered a gal-10 protein assembly in two distinguishable states: i.e., an insoluble crystalline state and a soluble state. The potency of the gal-10 protein in either the crystalline state or the soluble state to induce chemokine or cytokine release in the primary human nasal epithelial cells and nasal polyps derived from chronic rhinosinusitis patients with nasal polyps was investigated. The crystalline gal-10 upregulated the gene expression of chemokines or cytokines, including IL-1 beta, IL-6, IL-8, TNF-alpha, and GM-CSF, in patient-derived primary cells and nasal polyps. In contrast, soluble gal-10 displayed a diminished potency to induce inflammation. Our results demonstrate that the gal-10 protein potency of activating inflammation is correlated with its crystalline state.
基金:
This work was supported by the program for the Changjiang
scholars and innovative research team (IRT13082), the
National Natural Science Foundation of China (31901007,
81970852, 82000962, and 82171110), the Fundamental
Research Funds for the Central Universities (3332021039),
the Beijing Natural Science Foundation (2222039), the CAMS
Innovation Fund for Medical Sciences (2021-I2M-1-022 and
2019-I2M-5-022), the Overseas Expertise Introduction Center
for Discipline Innovation (“111Center”) (BP0820029), the
Beijing municipal science and technology project
(Z181100001618002), and the State Key Laboratory Special
Fund (2060204).
第一作者机构:[1]Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, People’s Republic of China[2]Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing 100005, China
共同第一作者:
通讯作者:
通讯机构:[1]Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, People’s Republic of China[2]Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing 100005, China[3]State Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Beijing 100005, People’s Republic of China[5]Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, People’s Republic of China[*1]Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, People’s Republic of China[*2]Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing 100005, China[*3]State Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Beijing 100005, People’s Republic of China[*4]Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, People’s Republic of China
推荐引用方式(GB/T 7714):
Yan Zhao,Shanshan Mo,Lanlan Yu,et al.Crystalline State Determines the Potency of Galectin-10 Protein Assembly to Induce Inflammation[J].NANO LETTERS.2022,22(6):2350-2357.doi:10.1021/acs.nanolett.1c04817.
APA:
Yan Zhao,Shanshan Mo,Lanlan Yu,Xiaolu Li,Yun Hao...&Luo Zhang.(2022).Crystalline State Determines the Potency of Galectin-10 Protein Assembly to Induce Inflammation.NANO LETTERS,22,(6)
MLA:
Yan Zhao,et al."Crystalline State Determines the Potency of Galectin-10 Protein Assembly to Induce Inflammation".NANO LETTERS 22..6(2022):2350-2357